Cetera Investment Advisers
BBH icon

Cetera Investment Advisers’s VanEck Biotech ETF BBH Stock Holding History

Cetera Investment Advisers’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$397K Sell
1,951
-104
-5% -$19.6K ﹤0.01% 3907
2026
Q1 		$386K Sell
2,055
-49
-2% -$9.44K ﹤0.01% 3751
2025
Q4 		$398K Sell
2,104
-32
-1% -$5.92K ﹤0.01% 3643
2025
Q3 		$354K Buy
2,136
+105
+5% +$17.1K ﹤0.01% 3696
2025
Q2 		$311K Sell
2,031
-1,063
-34% -$158K ﹤0.01% 3363
2025
Q1 		$487K Buy
3,094
+423
+16% +$68.7K ﹤0.01% 2858
2024
Q4 		$419K Buy
2,671
+404
+18% +$68K ﹤0.01% 2816
2024
Q3 		$402K Buy
2,267
+72
+3% +$12.8K ﹤0.01% 2837
2024
Q2 		$370K Sell
2,195
-3,561
-62% -$582K ﹤0.01% 2839
2024
Q1 		$957K Buy
+5,756
New +$953K ﹤0.01% 2104
2023
Q2 		– Sell
-2,500
Closed -$405K – 2204
2023
Q1 		$405K Sell
2,500
-70
-3% -$11.3K ﹤0.01% 1542
2022
Q4 		$411K Buy
+2,570
New +$407K ﹤0.01% 1482
2022
Q3 		– Sell
-2,726
Closed -$397K – 1738
2022
Q2 		$397K Sell
2,726
-2,230
-45% -$332K 0.01% 1240
2022
Q1 		$804K Sell
4,956
-1,418
-22% -$230K 0.01% 897
2021
Q4 		$1.21M Buy
6,374
+16
+0.3% +$3.08K 0.02% 741
2021
Q3 		$1.28M Buy
6,358
+3,596
+130% +$755K 0.02% 687
2021
Q2 		$557K Sell
2,762
-710
-20% -$132K 0.01% 1064
2021
Q1 		$609K Sell
3,472
-22
-0.6% -$3.98K 0.01% 871
2020
Q4 		$593K Buy
+3,494
New +$576K 0.01% 884

Other funds holding BBH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
CCA
Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Cetera Investment Advisers's BBH Position: Q2 2026 in Review

Cetera Investment Advisers reduced its VanEck Biotech ETF (BBH) stake by 5.1% in Q2 2026, selling an estimated $19.6K and leaving 1,951 shares worth $397K. The position accounts for ﹤0.01% of the portfolio, ranked #3907.

Cetera Investment Advisers first reported a position in BBH in Q4 2020 and has held it in 19 quarters since. The position peaked at $1.28M in Q3 2021. 110 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

  • Cetera Investment Advisers held 1,951 shares of VanEck Biotech ETF worth $397K as of Q2 2026.
  • Cetera Investment Advisers sold 104 VanEck Biotech ETF shares in Q2 2026, an estimated $19.6K.
  • VanEck Biotech ETF made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #3907 holding.
  • Cetera Investment Advisers first reported a position in VanEck Biotech ETF in Q4 2020 and has held it in 19 quarters since.
  • Cetera Investment Advisers's VanEck Biotech ETF position peaked at $1.28M in Q3 2021.
  • 110 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.